Yanqiao M. Ren

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 73 publications

Association of AI-Assisted Training with Learning Outcomes in Lung Cancer Puncture Ablation: A Retrospective Before-and-After Study.

Association of AI-Assisted Training with Learning Outcomes in Lung Cancer Puncture Ablation: A Retrospective Before-and-After Study.

Journal: Advances in medical education and practice

Published: June 13, 2026

Calcification-Mediated Dual-Starvation and Immune Activation for Transarterial Chemoembolization.

Calcification-Mediated Dual-Starvation and Immune Activation for Transarterial Chemoembolization.

Journal: International journal of nanomedicine

Published: March 27, 2026

Percutaneous Transhepatic Cholangiodrainage (PTCD)-Related Hepatitis B Virus Reactivation in Obstructive Jaundice.

Percutaneous Transhepatic Cholangiodrainage (PTCD)-Related Hepatitis B Virus Reactivation in Obstructive Jaundice.

Journal: Journal of clinical medicine

Published: February 27, 2026

Construction of ATOX1 targeted nano gel based on cuproptosis mechanism and its role in reversing TACE refractoriness of hepatocellular carcinoma.

Construction of ATOX1 targeted nano gel based on cuproptosis mechanism and its role in reversing TACE refractoriness of hepatocellular carcinoma.

Journal: Journal of nanobiotechnology

Published: February 06, 2026

Efficacy and Safety of HAIC Combined with PD-(L)1 Inhibitors and Bevacizumab Versus HAIC with PD-(L)1 Inhibitors and TKIs in Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study.

Efficacy and Safety of HAIC Combined with PD-(L)1 Inhibitors and Bevacizumab Versus HAIC with PD-(L)1 Inhibitors and TKIs in Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study.

Journal: Cancers

Published: November 28, 2025

One-stop Management of Massive Hemoptysis: Intraprocedural Angio-CT Guidance for Bronchial Artery Embolization.

One-stop Management of Massive Hemoptysis: Intraprocedural Angio-CT Guidance for Bronchial Artery Embolization.

Journal: Archivos de bronconeumologia

Published: November 04, 2025

Outcome of adding percutaneous transhepatic cholangial drainage to DEB-TACE in patients with unresectable cholangiocarcinoma with obstructive jaundice: comparison with sole DEB-TACE.

Outcome of adding percutaneous transhepatic cholangial drainage to DEB-TACE in patients with unresectable cholangiocarcinoma with obstructive jaundice: comparison with sole DEB-TACE.

Journal: Therapeutic advances in gastroenterology

Published: April 01, 2025

Long-term efficacy of transarterial chemoembolization in the treatment of recurrent hepatocellular carcinoma.

Long-term efficacy of transarterial chemoembolization in the treatment of recurrent hepatocellular carcinoma.

Journal: BMC gastroenterology

Published: March 20, 2025

The effect of Angio-CT on the efficacy of hemoptysis patients with non-bronchial systemic arteries-a retrospective study.

The effect of Angio-CT on the efficacy of hemoptysis patients with non-bronchial systemic arteries-a retrospective study.

Journal: Cardiovascular diagnosis and therapy

Published: December 30, 2024

FOLFOX-HAIC plus regorafenib for the treatment of unresectable colorectal liver metastases refractory to first and second-line systemic chemotherapy.

FOLFOX-HAIC plus regorafenib for the treatment of unresectable colorectal liver metastases refractory to first and second-line systemic chemotherapy.

Journal: BMC cancer

Published: October 25, 2024

Transarterial Chemoembolization Plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-Risk Locations: A Propensity Score-Matched Analysis.

Transarterial Chemoembolization Plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-Risk Locations: A Propensity Score-Matched Analysis.

Journal: Journal of hepatocellular carcinoma

Published: October 25, 2024

Efficacy and Safety of TACE Combined with Regorafenib versus TACE Combined with Camrelizumab in Hepatocellular Carcinoma With Untreatable Progression After TACE Combined with Sorafenib Therapy: A Case Control Study.

Efficacy and Safety of TACE Combined with Regorafenib versus TACE Combined with Camrelizumab in Hepatocellular Carcinoma With Untreatable Progression After TACE Combined with Sorafenib Therapy: A Case Control Study.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: August 20, 2024

Showing 1-12 of 73

Last Updated: 09/26/2026